Literature DB >> 11823679

What is effective in malignant middle cerebral artery infarction: reperfusion, craniectomy, or both? An experimental study in rats.

T Engelhorn1, R von Kummer, W Reith, M Forsting, A Doerfler.   

Abstract

BACKGROUND AND
PURPOSE: We sought to evaluate the effects of reperfusion and craniectomy treatment at different time points after middle cerebral artery (MCA) occlusion on infarct volume and neurological outcome in MCA infarction in rats.
METHODS: We used an endovascular technique to obtain MCA occlusion in 182 rats. Thirteen groups with 14 animals each were investigated: control group 1 with no treatment; groups 2 to 7 with only reperfusion or craniectomy at 1, 4, or 12 hours, respectively; and groups 8 to 13 with reperfusion at 1 or 4 hours combined with craniectomy at 1, 4, or 12 hours, respectively. We used infarct volume and neurological performance as study end points in all animals at day 7.
RESULTS: Neurological score and infarct volume in animals undergoing early reperfusion at 1 hour were significantly smaller (1.8/79+/-59 mm3) than those in control animals (3.8/225+/-26 mm3) (P<0.01). Reperfusion at 4 hours (2.8/182+/-62 mm3) and 12 hours (3.7/231+/-69 mm3) did not result in significant improvement. Animals undergoing craniectomy at 1, 4, and 12 hours demonstrated significantly better outcome and significantly reduced infarct volume (1.6/96+/-30 mm3, 1.9/109+/-39 mm3, and 2.6/150+/-34 mm3, respectively) (P<0.05). Compared with 1 treatment at a time, combined reperfusion and craniectomy did not result in a significant additional benefit.
CONCLUSIONS: Early reperfusion and craniectomy at 1 hour are both effective in large MCA infarction. While reperfusion later than 1 hour was not beneficial, late craniectomy at 4 and 12 hours still resulted in significant improvement of neurological score and reduction of infarction size. Combined treatment at different time points yields no significant additional benefit compared with 1 treatment at a time.

Entities:  

Mesh:

Year:  2002        PMID: 11823679     DOI: 10.1161/hs0202.102374

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  The Role of Vascular Imaging in the Initial Assessment of Patients with Acute Ischemic Stroke.

Authors:  Emmad Qazi; Fahad S Al-Ajlan; Mohamed Najm; Bijoy K Menon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

2.  Decompressive craniectomy and mild hypothermia reduces infarction size and counterregulates Bax and Bcl-2 expression after permanent focal ischemia in rats.

Authors:  Bian Jieyong; Wang Zhong; Zhang Shiming; Zhou Dai; Yoko Kato; Tetsuo Kanno; Hirotoshi Sano
Journal:  Neurosurg Rev       Date:  2006-01-10       Impact factor: 3.042

3.  TCD systolic spikes in a malignant MCA infarct.

Authors:  Jesus Perez-Nellar; Claudio Scherle; Calixto Machado
Journal:  Neurocrit Care       Date:  2009-04-18       Impact factor: 3.210

4.  Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.

Authors:  J Marc Simard; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Vladimir Yurovsky; Volodymyr Gerzanich
Journal:  Stroke       Date:  2010-01-21       Impact factor: 7.914

5.  Delayed decompressive craniectomy improves the long-term outcomes in hypertensive rats with space-occupying cerebral infarction.

Authors:  Zhan Zhao; Jian Yu; Songjie Liao; Li Xiong; Zhijian Liang; Li Ling; Fang Wang; Qinghua Hou; Wenliang Zhou; Zhong Pei; Jinsheng Zeng
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

6.  Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine Model.

Authors:  Annabel J Sorby-Adams; Anna V Leonard; Levi E Elms; Oana C Marian; Jan W Hoving; Nawaf Yassi; Robert Vink; Emma Thornton; Renée J Turner
Journal:  Front Neurosci       Date:  2019-07-09       Impact factor: 4.677

7.  Neuroprotective mechanisms of erythropoietin in a rat stroke model.

Authors:  Martin Juenemann; Tobias Braun; Nadine Schleicher; Mesut Yeniguen; Patrick Schramm; Tibo Gerriets; Nouha Ritschel; Georg Bachmann; Martin Obert; Markus Schoenburg; Manfred Kaps; Marlene Tschernatsch
Journal:  Transl Neurosci       Date:  2020-05-18       Impact factor: 1.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.